HYBRID EVENT: Join us in person in Tokyo, Japan or attend virtually from anywhere.

World Aging & Longevity Conference

October 08-10, 2026

Nicotinamide Mononucleotide Aging

Nicotinamide Mononucleotide Aging

Nicotinamide mononucleotide aging refers to biological effects of nicotinamide mononucleotide on aging-related metabolic decline. Nicotinamide mononucleotide is a direct NAD precursor involved in intracellular NAD biosynthesis. With aging, reduced NAD availability limits cellular energy production and repair capacity. Nicotinamide mononucleotide aging research explores restoration of metabolic efficiency, mitochondrial performance, and cellular homeostasis. By replenishing NAD pools, this approach may support tissue function and stress resilience. Nicotinamide mononucleotide aging represents a targeted strategy within metabolic longevity research aimed at addressing age-related energy failure and functional decline.

Committee Members
Speaker at Geriatrics Conference - Kenneth R Pelletier

Kenneth R Pelletier

University of California School of Medicine, United States
Speaker at Aging Conferences - Thomas J Webster

Thomas J Webster

Brown University, United States
Speaker at Aging Conferences - Jason Beckwith

Jason Beckwith

BioTalent, United Kingdom
WALC 2026 Speakers
Speaker at Aging Conferences - Sergey Suchkov

Sergey Suchkov

N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Speaker at Geriatrics Conference - Jose Cordeiro Mateo

Jose Cordeiro Mateo

International Longevity Summit, Spain
Speaker at Aging Conferences - Ashot Khachatryan

Ashot Khachatryan

National Academy of Sciences of the Republic of Armenia, Armenia
Speaker at Aging Conferences - Utpol Das

Utpol Das

University of Texas Medical Branch at Galveston, United States
Tags

Submit your abstract Today

Youtube
Watsapp